Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services.

Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.